InvestorsHub Logo
Followers 17
Posts 1798
Boards Moderated 0
Alias Born 10/11/2007

Re: JimHaynes post# 12059

Tuesday, 10/23/2007 12:37:38 PM

Tuesday, October 23, 2007 12:37:38 PM

Post# of 51660
JH cutting Stoll some slack. Impressive. We will continue to deteriorate until some sort of hope is offered short term or long. That is all I am looking for at his point. Letting us know that he is concerned and indeed putting together or already has together a comprehensive plan to move forward on a expediated state to insure us of the unnecessary need for financing near term. Otherwise, the R&R price target is looking more accurate sooner than later. What hope of a bounce can we expect if we cannot sustain these levels. Give us something.

If no short term solution exists my prediction is a 1 for 10 reverse stock split followed by another pipe. This will ensure COR has the cash for a few more years of research allowing Stoll to finish his years out at the COR helm collecting on his retirement package. He is over 60 after all.

My hopes is that a buyout occurs soon at or above $1.50, otherwise I fear this is dead money for many years. I would much rather take what I can at this point than play the wait and see game for 2 more years with hopes that the FDA changed their self serving ways. Certainly Tech is hot right now and might offer many opportunities to recoupe the dollars from this mindnumbing debacle.

Does anyone here know of similar circumstances in COR's history that has allowed them to pull them from the depths of dispair. If indeed COR has been here before, which I believe they have, then history may repeat itself with the offering of another carrot and an SP bounce. I know COR was in more deperate times years ago. Are we taking it harder today because we were more visible on the radar and the negative binary created a much broader scale sell off? Or were the hopes of CX717 just that vital...that it's rejection affects the entire ampakine platform?
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent RSPI News